The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 15, 2012
Filed:
Jun. 05, 2009
Ho Young Song, Daejeon, KR;
Young Lag Cho, Daejeon, KR;
Dae Yon Lee, Daejeon, KR;
Hee Sock Park, Daejeon, KR;
Sung Yoon Baek, Daejeon, KR;
Sang Eun Chae, Daejeon, KR;
Sang Hui JO, Daejeon, KR;
Yeon OK Kim, Daejeon, KR;
Hyang Sook Lee, Daejeon, KR;
Ju Hyun Park, Daejeon, KR;
Tae Kyo Park, Daejeon, KR;
Sung Ho Woo, Daejeon, KR;
Yong Zu Kim, Daejeon, KR;
Ho Young Song, Daejeon, KR;
Young Lag Cho, Daejeon, KR;
Dae Yon Lee, Daejeon, KR;
Hee Sock Park, Daejeon, KR;
Sung Yoon Baek, Daejeon, KR;
Sang Eun Chae, Daejeon, KR;
Sang Hui Jo, Daejeon, KR;
Yeon Ok Kim, Daejeon, KR;
Hyang Sook Lee, Daejeon, KR;
Ju Hyun Park, Daejeon, KR;
Tae Kyo Park, Daejeon, KR;
Sung Ho Woo, Daejeon, KR;
Yong Zu Kim, Daejeon, KR;
Legochem Bioscience Ltd., Daejeon, KR;
Abstract
Disclosed are novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone group, pharmaceutically acceptable salts thereof, methods for preparing the same and pharmaceutical compositions containing the same. The oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone group or the pharmaceutically acceptable salts thereof can be effectively used for the treatment of thromboembolism and tumor as an anticoagulant based on the inhibition of factor Xa.